BACKGROUND: Small intestinal bacterial overgrowth (SIBO) occurs in irritable bowel syndrome (IBS) and fibromyalgia. Since restless legs syndrome (RLS) occurs with fibromyalgia, a link between IBS, SIBO, and RLS was studied. METHODS: BS patients with abnormal lactulose breath tests received rifaximin 1,200 mg day(-1) for 10 days, followed by tegaserod 3 mg, long-term, and 1 month of zinc 220 mg day(-1) and once-daily probiotic (N = 11) or rifaximin monotherapy (N = 2). IBS symptom improvement was assessed after rifaximin. RLS symptoms, IBS symptoms, and overall IBS global improvement were assessed at last posttreatment visit: 8/10 patients were followed long-term (mean, 139 days; range, 54-450 days). RESULTS: Ten of 13 patients exhibited > or =80% improvement from baseline in RLS symptoms. Five maintained complete resolution of RLS symptoms. Global gastrointestinal symptom improvement was great (n = 6), moderate (n = 5), or mild (n = 2). CONCLUSION: This study suggests that SIBO associated with IBS may be a factor in some RLS patients and SIBO therapy provides long-term RLS improvement.
BACKGROUND: Small intestinal bacterial overgrowth (SIBO) occurs in irritable bowel syndrome (IBS) and fibromyalgia. Since restless legs syndrome (RLS) occurs with fibromyalgia, a link between IBS, SIBO, and RLS was studied. METHODS: BS patients with abnormal lactulose breath tests received rifaximin 1,200 mg day(-1) for 10 days, followed by tegaserod 3 mg, long-term, and 1 month of zinc 220 mg day(-1) and once-daily probiotic (N = 11) or rifaximin monotherapy (N = 2). IBS symptom improvement was assessed after rifaximin. RLS symptoms, IBS symptoms, and overall IBS global improvement were assessed at last posttreatment visit: 8/10 patients were followed long-term (mean, 139 days; range, 54-450 days). RESULTS: Ten of 13 patients exhibited > or =80% improvement from baseline in RLS symptoms. Five maintained complete resolution of RLS symptoms. Global gastrointestinal symptom improvement was great (n = 6), moderate (n = 5), or mild (n = 2). CONCLUSION: This study suggests that SIBO associated with IBS may be a factor in some RLSpatients and SIBO therapy provides long-term RLS improvement.
Authors: Kishor B Raja; Gladys O Latunde-Dada; Timothy J Peters; Andrew T McKie; Robert J Simpson Journal: Br J Haematol Date: 2005-12 Impact factor: 6.998
Authors: Wayne A Hening; Richard P Allen; Stacey Thanner; Tinna Washburn; Debbie Heckler; Arthur S Walters; Christopher J Earley Journal: Sleep Med Date: 2003-03 Impact factor: 3.492
Authors: Leonard B Weinstock; Arthur S Walters; Jill B Brook; Zahid Kaleem; Lawrence B Afrin; Gerhard J Molderings Journal: J Clin Sleep Med Date: 2020-01-14 Impact factor: 4.062
Authors: Leonard B Weinstock; Brian P Bosworth; Ellen J Scherl; Ellen Li; Ugonna Iroku; Melissa A Munsell; Gerard E Mullin; Gerald E Mullen; Arthur S Walters Journal: Inflamm Bowel Dis Date: 2010-02 Impact factor: 5.325